Graft Versus Host Disease (GVHD) – Highly Promising Therapies in Pipeline

According to the latest report of DelveInsight, “Graft Versus Host Disease (GVHD) - Market Insights, Epidemiology, and Market Forecast-2027,” in 2016, there were 9,847 and 9,006 cases of aGvHD and cGvHD, respectively, in 7 MM. [PR.com]